Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
|
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears
    Ren, Chenchen
    Zhu, Yuanhang
    Yang, Li
    Zhang, Xiaoan
    Liu, Ling
    Ren, Chunying
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (02) : 425 - 432
  • [22] HPV E6 and E7 mRNA Test for the Detection of High-Grade Cervical Lesions
    Derbie, Awoke
    Maier, Melanie
    Amare, Bereket
    Misgan, Eyaya
    Nibret, Endalkachew
    Biadglegne, Fantahun
    Liebert, Uwe G.
    Minas, Tsion Zewdu
    Yenesew, Muluken Agage
    Nigatu, Dabere
    Mersha, Tesfaye B.
    Enquobahrie, Daniel A.
    Woldeamanuel, Yimtubezinash
    Abebe, Tamrat
    JAMA NETWORK OPEN, 2025, 8 (02)
  • [23] 高危型HPV E6/E7 mRNA检测对ASCUS患者分流价值的系统评价
    郎凯楠
    李文
    李亚平
    刘学友
    刘玉玲
    郑州大学学报(医学版), 2018, 53 (05) : 604 - 609
  • [24] Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
    Wu, Ming-Zhe
    Li, Wei-Nan
    Cha, Na
    Tian, Li-Xiang
    Zhang, Yi
    Wu, Xin
    Guo, Ke-Jun
    Wu, Guang-Ping
    CELL TRANSPLANTATION, 2018, 27 (09) : 1401 - 1406
  • [25] Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV)
    Lim, JiaWen
    Lilie, Hauke
    Kalbacher, Hubert
    Roos, Nora
    Frecot, Desiree Isabella
    Feige, Maximilian
    Conrady, Marcel
    Votteler, Tobias
    Cousido-Siah, Alexandra
    Bartoli, Giada Corradini
    Iftner, Thomas
    Trave, Gilles
    Simon, Claudia
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (08)
  • [26] HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
    Maria Teresa Bruno
    Martina Ferrara
    Valentina Fava
    Agnese Rapisarda
    Angela Coco
    Virology Journal, 15
  • [27] HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
    Bruno, Maria Teresa
    Ferrara, Martina
    Fava, Valentina
    Rapisarda, Agnese
    Coco, Angela
    VIROLOGY JOURNAL, 2018, 15
  • [28] Seropositivity of HPV 16 E6 and E7 and the risk of oral cancer
    Wong, G. R.
    Ha, K. O.
    Himratul-Aznita, W. H.
    Yang, Y. H.
    Mustafa, W. M. Wan
    Yuen, K. M.
    Abraham, M. T.
    Tay, K. K.
    Karen-Ng, L. P.
    Cheong, S. C.
    Zain, R. B.
    ORAL DISEASES, 2014, 20 (08) : 762 - 767
  • [29] Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study
    Ren, Chenchen
    Zhu, Yuanhang
    Yang, Li
    Zhang, Xiaoan
    Liu, Ling
    Wang, Zhaoxin
    Jiang, Dongyuan
    VIROLOGY JOURNAL, 2019, 16 (01)
  • [30] Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study
    Chenchen Ren
    Yuanhang Zhu
    Li Yang
    Xiaoan Zhang
    Ling Liu
    Zhaoxin Wang
    Dongyuan Jiang
    Virology Journal, 16